Fin Trust Capital Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Fin Trust Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$10.92 - $16.41 $300,300 - $451,275	-27,500 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$12.68 - $17.79 $348,700 - $489,225	27,500 New	27,500 $442,000
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $218,463 - $324,058	-15,150 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $33,120 - $37,880	-2,000 Reduced 11.66%	15,150 $266,000
Q3 2020 Nov 10, 2020	SELL	$17.41 - $19.89 $9,575 - $10,939	-550 Reduced 3.11%	17,150 $314,000
Q2 2020 Sep 11, 2020	BUY	$14.43 - $19.16 $111,111 - $147,532	7,700 Added 77.0%	17,700 $317,000
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $111,111 - $147,532	-7,700 Reduced 43.5%	10,000 $179,000
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $25,674 - $49,566	2,200 Added 14.19%	17,700 $287,000
Q4 2019 Jan 23, 2020	BUY	$16.33 - $21.37 $253,114 - $331,235	15,500 New	15,500 $279,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.